Wildy logo
(020) 7242 5778
enquiries@wildy.com

Wildy’s Book News

Book News cover photo

Vol 21 No 11 Nov/Dec 2016

Book of the Month

Cover of Criminal Injuries Compensation Claims

Criminal Injuries Compensation Claims

Price: £99.95

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


Pharmaceutical Innovation, Competition And Patent Law

Image not available lge

ISBN13: 9780857932457
Published: July 2013
Publisher: Edward Elgar Publishing Limited
Country of Publication: UK
Format: Hardback
Price: £96.00



Despatched in 3 to 5 days.

Public health, safety, and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination.

The contributors to this book including academics, judges and practitioners from Europe, US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care. Addressing fundamental questions in the field of pharmaceutical innovation, this book will appeal to scholars and practitioners in intellectual property, competition law and life sciences regulation, as well as pharmaceutical companies and regulators.

Image not available lge
Subjects:
Competition Law, Intellectual Property Law, Medical Law
Contents:
Introduction

PART I: PATENT PROTECTION FOR PHARMACEUTICAL METHODS
1. The Patentability of Genetic Diagnostics in U.S. Law and Policy
2. Patentability of Pharmaceutical Innovations - The European Perspective
3. Patentability of Medical Methods in Japan

PART II: DATA EXCLUSIVITY AND PATENT TERM EXTENSION - CONVERGENCE OR DIVERGENCE
4. Patent Term Restoration and Non-Patent Exclusivity in the United States
5. Clinical Data, Data Exclusivity and Private Investment Protection in Europe
6. Patent Term Extension in Japan - an Academic and Comparative Perspective
7. Recent United Kingdom Case Law On Supplementary Protection Certificates
8. Patent Term Extension in Japan - Focusing on the Pacif Capsule Decision
Apppendix Decision of Japanese Supreme Court, 28 April 2011

PART III: BALANCING INCENTIVES AND COMPETITION IN EUROPE
9. Strategic Patenting by Pharmaceutical Industry - Towards a Concept of Abusive Practices of Protection
10. Anticompetitive Marketing in the Context of Pharmaceutical Switching in Europe
11. AstraZeneca and the EU Sector Inquiry: When Do Patent Filings Violate Competition Law?

Index